CMCSA vs CVS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CMCSA Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Comcast Corp (CMCSA) driven by superior Valuation, Growth & Margin, Options & Structure while CVS counters with relative strength in Momentum & Technical. Fundamentally, CMCSA trades at 7.1x Forward P/E with 14.7% operating margin (-6.1% YoY revenue) versus CVS at 9.3x Forward P/E and 3.1% operating margin (+5.4% YoY). In options structure, CMCSA sits in CONSOLIDATION (30th %ile IV; Dealer Gamma Walls on Pro) against CVS sits in CONSOLIDATION (69th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CMCSA Revenue | CVS Revenue | CMCSA Op. Margin | CVS Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $94.5B | $193.9B | 20.1% | 2.1% | CMCSA |
| FY2019 | $108.9B | $256.8B | 19.4% | 4.7% | CMCSA |
| FY2020 | $103.6B | $268.7B | 16.9% | 5.2% | CMCSA |
| FY2021 | $116.4B | $292.1B | 17.9% | 4.6% | CMCSA |
| FY2022 | $121.4B | $322.5B | 11.6% | 2.5% | CMCSA |
| FY2023 | $121.6B | $357.8B | 19.2% | 3.8% | CMCSA |
| FY2024 | $123.7B | $372.8B | 18.8% | 2.3% | CMCSA |
| FY2025 | $123.7B | $402.1B | 16.7% | 1.2% | CMCSA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CMCSA | CVS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $88.3B | $102.4B | Larger Scale | CVS |
| Trailing P/E Ratio Valuation | 7.9x | 9.3x | Lower Multiple | CMCSA |
| Forward P/E Ratio Valuation | 7.1x | 9.3x | Lower Multiple | CMCSA |
| Revenue Growth (YoY) Growth | -6.1% | +5.4% | Higher Growth | CVS |
| Operating Margin (TTM) Profitability | 14.7% | 3.1% | Higher Margin | CMCSA |
| Net Profit Margin Profitability | 9.2% | 2.6% | Higher Margin | CMCSA |
| Return on Equity (ROE) Capital Efficiency | 11.4% | 14.4% | Higher ROE | CVS |
| 52-Week Range Position Momentum | 36% ($20โ$33) | 28% ($70โ$111) | Stronger Trend | CMCSA |
| Beta / 30D Volatility Risk Regime | -0.01ฮฒ ยท 32% Vol | -0.03ฮฒ ยท 54% Vol | Lower Realized Risk | CMCSA |
| Unified Institutional Score Composite Signal | 32.8 / 100 (SELL) | 62.6 / 100 (BUY) | Higher Composite | CVS |